These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12007919)
1. Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord. Mauborgne A; Poliénor H; Hamon M; Cesselin F; Bourgoin S Eur J Pharmacol; 2002 Apr; 441(1-2):47-55. PubMed ID: 12007919 [TBL] [Abstract][Full Text] [Related]
2. Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices. Bourgoin S; Pohl M; Mauborgne A; Benoliel JJ; Collin E; Hamon M; Cesselin F Neuropharmacology; 1993 Jul; 32(7):633-40. PubMed ID: 7689707 [TBL] [Abstract][Full Text] [Related]
3. gamma-Aminobutyric acid, through GABAA receptors, inhibits the potassium-stimulated release of calcitonin gene-related peptide- but not that of substance P-like material from rat spinal cord slices. Bourgoin S; Pohl M; Benoliel JJ; Mauborgne A; Collin E; Hamon M; Cesselin F Brain Res; 1992 Jun; 583(1-2):344-8. PubMed ID: 1380400 [TBL] [Abstract][Full Text] [Related]
4. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Nakamura I; Ohta Y; Kemmotsu O Anesthesiology; 1997 Sep; 87(3):577-84. PubMed ID: 9316963 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats. Sjölund KF; Sollevi A; Segerdahl M; Lundeberg T Anesth Analg; 1997 Sep; 85(3):627-32. PubMed ID: 9296420 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of the novel analgesic, S 12813-4, on the spinal release of substance P- and calcitonin gene-related peptide-like materials in the rat. Collin E; Frechilla D; Pohl M; Bourgoin S; Mauborgne A; Hamon M; Cesselin F Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):387-93. PubMed ID: 7520130 [TBL] [Abstract][Full Text] [Related]
7. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Vasko MR; Ono H Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):441-6. PubMed ID: 1701522 [TBL] [Abstract][Full Text] [Related]
8. Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO. Nieri P; Martinotti E; Calderone V; Breschi MC Br J Pharmacol; 2001 Oct; 134(4):745-52. PubMed ID: 11606314 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of strychnine-allodynia is mediated by spinal adenosine A1- but not A2-receptors in the rat. Khandwala H; Zhang Z; Loomis CW Brain Res; 1998 Oct; 808(1):106-9. PubMed ID: 9795169 [TBL] [Abstract][Full Text] [Related]
12. Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord. Santicioli P; Del Bianco E; Tramontana M; Maggi CA Neurosci Lett; 1992 Sep; 144(1-2):211-4. PubMed ID: 1279486 [TBL] [Abstract][Full Text] [Related]
13. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat. Ballet S; Mauborgne A; Benoliel JJ; Bourgoin S; Hamon M; Cesselin F; Collin E Brain Res; 1998 Jun; 796(1-2):198-208. PubMed ID: 9689470 [TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptor antagonists inhibit sensory neuropeptide release from the rat spinal cord. Saria A; Javorsky F; Humpel C; Gamse R Neuroreport; 1990 Oct; 1(2):104-6. PubMed ID: 1717037 [TBL] [Abstract][Full Text] [Related]
15. The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats. Ballet S; Aubel B; Mauborgne A; Poliénor H; Farré A; Cesselin F; Hamon M; Bourgoin AS Neuropharmacology; 2001 Mar; 40(4):578-89. PubMed ID: 11249967 [TBL] [Abstract][Full Text] [Related]
16. Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids. Bourgoin S; Benoliel JJ; Collin E; Mauborgne A; Pohl M; Hamon M; Cesselin F Fundam Clin Pharmacol; 1994; 8(4):307-21. PubMed ID: 7851837 [TBL] [Abstract][Full Text] [Related]
17. Increased calcitonin gene-related peptide- and cholecystokinin-like immunoreactivities in spinal motoneurones after dorsal rhizotomy. Taquet H; Plachot JJ; Pohl M; Collin E; Benoliel JJ; Bourgoin S; Mauborgne A; Meunier JC; Cesselin F; Hamon M J Neural Transm Gen Sect; 1992; 88(2):127-41. PubMed ID: 1378744 [TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Oku R; Satoh M; Fujii N; Otaka A; Yajima H; Takagi H Brain Res; 1987 Feb; 403(2):350-4. PubMed ID: 2435372 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteries. Hedegaard ER; Nielsen BD; Mogensen S; Rembold CM; Frøbert O; Simonsen U Eur J Pharmacol; 2014 Jan; 723():216-26. PubMed ID: 24309216 [TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. Malcangio M; Garrett NE; Tomlinson DR Eur J Neurosci; 1997 May; 9(5):1101-4. PubMed ID: 9182964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]